You have 9 free searches left this month | for more free features.

Esophageal Squamous Cell Carcinoma(cT3-4aN0-1M0)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Cancer Trial in Moscow (Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.,

Recruiting
  • Esophageal Cancer
  • Patients undergoing neoadjuvant chemoradiotherapy plus Ivory-Lewis or McKeown esophagectomy.
  • Patients undergoing neoadjuvant chemotherapy plus Ivory-Lewis or McKeown esophagectomy
  • Moscow, Russian Federation
    N.N. Blokhin National Medical Research Center of Oncology
Oct 2, 2022

Esophageal Squamous Cell Carcinoma Stage cT3-4aN0-1M0 Trial in Shanghai (Neoadjuvant Chemoradiotherapy, Neoadjuvant

Completed
  • Esophageal Squamous Cell Carcinoma Stage cT3-4aN0-1M0
  • Neoadjuvant Chemoradiotherapy
  • +2 more
  • Shanghai, Shanghai, China
    Shanghai Zhongshan Hospital
Sep 7, 2020

Oral Cancer, PD-1 Trial in Guangzhou (PD-1 with chemo, upright surgery)

Recruiting
  • Oral Cancer
  • PD-1
  • PD-1 with chemotherapy
  • upright surgery
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Nov 12, 2023

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chemotherapy (nab-paclitaxel AUC=2 and carboplatin 80mg/m2),Immunotherapy (camrelizumab 200mg)、Radiotherapy(primary lesion and adjacent lymph nodes 41.4Gy, distant lymph node 0.5Gy*4)
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Dec 6, 2022

Esophageal Squamous Cell Carcinoma Trial in Tokyo (Chemoradiotherapy)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chemoradiotherapy
  • Tokyo, Japan
    National Cancer Center Hospital
Apr 5, 2022

Oral Squamous Cell Carcinoma, Neck Dissection Trial (Elective neck dissection, Therapeutic neck dissection)

Not yet recruiting
  • Oral Squamous Cell Carcinoma
  • Neck Dissection
  • Elective neck dissection
  • Therapeutic neck dissection
  • (no location specified)
Apr 10, 2023

Esophageal Squamous Cell Carcinoma Abdominal Stage 0 Trial in Guangzhou (PD-1 Inhibitors, Irinotecan, Capecitabine tablets)

Recruiting
  • Esophageal Squamous Cell Carcinoma Abdominal Stage 0
  • PD-1 Inhibitors
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 20, 2023

Non-metastatic, Non-recurrent Lung and Esophageal Cancer

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +55 more
  • Biospecimen Collection
  • +3 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 5, 2023

Esophageal Cancer Trial (SDD)

Not yet recruiting
  • Esophageal Cancer
  • (no location specified)
May 9, 2023

Early Supraglottic Squamous Cell Carcinoma With Advance

Recruiting
  • Supraglottic Squamous Cell Carcinoma
  • Early Stage (T1-T2, N0-N1,M0)
  • TORS
  • Yvoir, Namur, Belgium
    CHU UCL Namur
Nov 3, 2022

Esophageal Squamous Cell Carcinoma Trial in Fuzhou (adjuvant treatment)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • adjuvant treatment
  • Fuzhou, Fujian, China
    Fujian Medical University Union Hospital
Nov 10, 2021

Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

Active, not recruiting
  • Oropharyngeal Cancer
  • Prince George, British Columbia, Canada
  • +13 more
Dec 12, 2022

HNSCC, Oral Cancer, PD-1 Trial in Guangzhou (Perbolizumab+Carboplatin+albumin-bound paclitaxel:4 courses,

Recruiting
  • HNSCC
  • +2 more
  • Perbolizumab+Carboplatin+albumin-bound paclitaxel:4 courses
  • Perbolizumab+Carboplatin+albumin-bound paclitaxel:2 courses
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Aug 6, 2023

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

Recruiting
  • Mouth Neoplasms
  • Carcinoma, Squamous Cell
  • TPF induction chemotherapy
  • +2 more
  • Shanghai, Shanghai, China
    Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
Oct 5, 2022

Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Head Neck Cancer Trial in United States (Lenvatinib

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 13, 2022

Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)

Not yet recruiting
  • Non-melanoma Skin Cancer
  • +3 more
  • Calgary, Alberta, Canada
  • +7 more
Jul 13, 2023

Advanced Cancer, Advanced Solid Tumor, Tumor Malignant Trial in United Kingdom (Fosifloxuridine Nafalbenamide, Leucovorin,

Not yet recruiting
  • Advanced Cancer
  • +16 more
  • Fosifloxuridine Nafalbenamide
  • +3 more
  • Birmingham, United Kingdom
  • +3 more
Feb 1, 2023

Esophageal Squamous Cell Carcinoma, Neoadjuvant Chemoimmunotherapy Trial (neoadjuvant anti-PD-1 (Keytruda) plus chemo)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Neoadjuvant Chemoimmunotherapy
  • neoadjuvant anti-PD-1 (Keytruda) plus chemotherapy
  • (no location specified)
Feb 14, 2023

Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in Worldwide (volrustomig)

Not yet recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Prescott Valley, Arizona
  • +71 more
Nov 10, 2023

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Advanced Solid Tumor Trial in United Kingdom, United States (CDK-002)

Active, not recruiting
  • Advanced Solid Tumor
  • CDK-002
  • Scottsdale, Arizona
  • +7 more
Sep 27, 2022

Remote Telemonitoring of Patient-Generated Physiologic Health

Recruiting
  • Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
  • +171 more
  • Patient Monitoring
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
Aug 15, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma in Cervical Lymph Node Trial in Houston

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Squamous Cell Carcinoma in Cervical Lymph Node
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Melanoma, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in Australia (AI-061)

Not yet recruiting
  • Melanoma
  • +16 more
  • Darlinghurst, New South Wales, Australia
  • +3 more
May 12, 2023